Lipids News and Research RSS Feed - Lipids News and Research

Lipids are a broad group of naturally-occurring molecules which includes fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E and K), monoglycerides, diglycerides, phospholipids, and others. The main biological functions of lipids include energy storage, as structural components of cell membranes, and as important signaling molecules.
Sleep and metabolic disorders: an interview with Professor Bernd Schultes, eSwiss Medical and Surgical Centre, St Gallen, Switzerland

Sleep and metabolic disorders: an interview with Professor Bernd Schultes, eSwiss Medical and Surgical Centre, St Gallen, Switzerland

Metabolic disorders are alterations in metabolic processes that can cause harm to a subject. The most common disorders affect the glucose and lipid metabolism causing diabetes and dyslipidemia. Another common disorder is obesity that affects many distinct metabolic processes. [More]
Scientists develop DNA nanodevices that survive body's immune defenses

Scientists develop DNA nanodevices that survive body's immune defenses

It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system. [More]
Researchers develop first size-based form of chromatography using nanodot technology

Researchers develop first size-based form of chromatography using nanodot technology

Using nanodot technology, Berkeley Lab researchers have demonstrated the first size-based form of chromatography that can be used to study the membranes of living cells. [More]
Concise analysis of global bioactive ingredients market

Concise analysis of global bioactive ingredients market

The report "Bioactive Ingredients & Product Market by Ingredient (Probiotics, Proteins, Plant Extracts, Minerals, Vitamins, Fibers, Carotenoids), by Product (Functional Foods, & Beverage, Dietary Supplements, Animal Nutrition, Personal Care) - Global trends & forecast to 2018", is published by MarketsandMarkets. [More]
Researchers identify mechanism that explains reason for persistence of hepatitis C virus

Researchers identify mechanism that explains reason for persistence of hepatitis C virus

Researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease and why the virus is able to persist in the body for so long. [More]

Lipid-based protein delivery system efficiently transports proteins into living cells

BioPORTER® Protein Delivery Reagent from AMSBIO is a unique lipid formulation that allows direct translocation of proteins into living cells. [More]

Abnormal levels of lipid molecules can trigger autism during prenatal brain development

In a groundbreaking York University study, researchers have found that abnormal levels of lipid molecules in the brain can affect the interaction between two key neural pathways in early prenatal brain development, which can trigger autism. [More]

Study shows PET imaging monitors prostate cancer progression without need for so many biopsies

Your body's cells have two major interconnected energy sources: the lipid metabolism and the glucose metabolism. Most cancers feed themselves by metabolizing glucose, and thus can be seen in Positron Emission Topography (PET) scans that detect radiolabeled glucose. [More]
Deutsche Forschungsgemeinschaft to establish 5 new Research Units

Deutsche Forschungsgemeinschaft to establish 5 new Research Units

Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years [More]
Study looks at ability of nontoxic molecules to store harmful alpha emitting radioisotopes

Study looks at ability of nontoxic molecules to store harmful alpha emitting radioisotopes

Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and effective storage lockers for harmful isotopes that emit ionizing radiation for treating tumors. [More]
Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol. [More]
Some people experience worse cholesterol levels during colder months

Some people experience worse cholesterol levels during colder months

Cholesterol levels fluctuate based on the time of year with more unfavorable lipid profiles seen in the colder months, a trend that may be driven by related behavior changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Researchers review influence of lipid rafts on progression of Alzheimer's disease

Research over decades has implicated aberrant autophagy and lysosomal function as reliable markers and therapeutic targets for neurodegenerative diseases. [More]
Polymer Technology Systems changes its name to Chek Diagnostics

Polymer Technology Systems changes its name to Chek Diagnostics

Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of point-of-care diagnostic products, announced today that it is changing its name to Chek Diagnostics. [More]
Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed reports results from ARIKAYCE phase 2 trial for treatment resistant NTM lung infections

Insmed Incorporated today reported results from the Company's phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections. [More]

Researchers receive grants to advance work in prevention of premature birth

Researchers at UT Southwestern Medical Center received grants totaling $600,000 from the March of Dimes Foundation to advance their work in the prevention of premature birth, which affects about one out of nine babies born annually in the U.S. and is the leading cause of newborn death. [More]

UTSW awarded March of Dimes grants to advance work in prevention of premature birth

Researchers at UT Southwestern Medical Center received grants totaling $600,000 from the March of Dimes Foundation to advance their work in the prevention of premature birth, which affects about one out of nine babies born annually in the U.S. and is the leading cause of newborn death. [More]

Research aims to develop world's first lipid database for healthy persons

A new international research consortium, led by the National University of Singapore (NUS), aims to develop the world's first lipid database for healthy persons of different racial and ethnic groups. [More]
New data shows curative effects of GFT505 in NASH associated with metabolic disorders

New data shows curative effects of GFT505 in NASH associated with metabolic disorders

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new data from Professor Isabelle Leclercq of Université Catholique de Louvain (Belgium) demonstrating the curative effects of GFT505 in an experimental model of NASH associated with metabolic disorders. [More]

Researchers discover potential new therapeutic target for controlling high blood sugar

A UT Southwestern Medical Center study has identified a new potential therapeutic target for controlling high blood sugar, a finding that could help the estimated 25 million Americans with type 2 diabetes. [More]